Universal Health Services (UHS) insider trading
Insider activity, historical context and SEC filings · data through Nov 20, 2026
No open-market insider buying in the last 12 months. Selling alone is common (taxes, diversification) and isn't treated as a signal here.
Label: Net selling · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.Sale Elliot J. Md Mba Sussman, Director sold 356 shares at $193.37 ($69K).
- Trade date
- Mar 13, 2026
- Disclosed to the SEC
- Mar 13, 2026
- Type
- Sale (code S)
Read the original SEC filing ↗All UHS insider trades ↓
Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.
UHS insider transactions (Form 4)
Open-market purchases and sales. 80 grants, option exercises and tax withholdings are not shown.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Mar 13SEC | Elliot J. Md Mba SussmanDirector | Sell | 3566,113 held (−6%) | $193.37 | $69K | -9.2% | — |
| Mar 13SEC | Elliot J. Md Mba SussmanDirector | Sell | 3186,113 held (−5%) | $186.35 | $59K | -5.7% | — |
| Nov 12SEC | Warren J. NimetzDirector | Sell | 3,6758,623 held (−30%) | $223.28 | $821K | -21.3% | — |
| Nov 12SEC | Warren J. NimetzDirector | Sell | 1428,481 held (−2%) | $223.96 | $32K | -21.6% | — |
| Oct 30SEC | Elliot J. Md Mba SussmanDirector | Sell | 9656,113 held (−14%) | $225.70 | $218K | -22.2% | — |
Similar past setups: not applicable. UHS has had no open-market insider purchases in the last 12 months, so there's no buying setup to compare with history. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →
Play with UHS in the Research Lab
UHS has no open-market insider buys in the last 12 months. Try the tools with any setup.
Quick backtest: did buys like this beat the market?
Tap a setting to see how 6,290 past insider buys did.
Share price and insider trades
Universal Health Services insider trading at a glance (Nov 20, 2026): in the past 12 months, 0 insiders bought $0 and 1 sold $128K of UHS stock on the open market; P/E 8.3 vs. a sector median of 25.0.
By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings, FINRA short-sale volume · How we calculate this
UHS insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | — | 0 |
| Q2 2026 | — | 0 | — | 0 |
| Q1 2026 | — | 0 | $128K | 2 |
| Q4 2025 | — | 0 | $1.1M | 3 |
Valuation, profit and volume
Source: Yahoo Finance, as of Nov 16, 2026. Volume and paper profit use daily closing prices.
Summary
Over the past 12 months, 0 Universal Health Services insiders reported open-market purchases totaling $0, while 1 insider reported sales totaling $128K. 0 of 5 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
UHS earnings: how the stock reacted
Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.
| Release | 15 days before | Insiders, 30 days before | Reaction (2 days) | Next 30 days |
|---|---|---|---|---|
| Jul 28, 2026 | +2.4% | None | +5.6%S&P -1.3% | +2.1% |
| Apr 28, 2026 | -0.7% | None | -6.4%S&P -0.5% | -13.0% |
| Feb 26, 2026 | +8.4% | None | -10.7%S&P -1.0% | -10.6% |
| Oct 28, 2025 | +9.1% | None | +5.3%S&P +0.3% | +8.1% |
| Jul 29, 2025 | -15.1% | None | +6.8%S&P -0.4% | +9.8% |
| Apr 29, 2025 | -1.4% | None | +2.4%S&P +0.7% | +7.5% |
| Feb 27, 2025 | -3.1% | None | -2.7%S&P -0.1% | +6.4% |
| Oct 25, 2024 | +5.5% | None | -9.0%S&P +0.3% | -0.5% |
Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.
UHS short selling
Daily short-sale volume as a share of trading volume (FINRA), with the 20-day average.
This is short volume from off-exchange trades, not short interest. It includes market makers' routine hedging, so 40–50% is normal; what stands out is a ratio well above the stock's own average. Insiders buying while shorts pile in →
Members of Congress who traded UHS
From STOCK Act disclosures. Reported up to 45 days after the trade, in dollar ranges.
| Member | Trade | Traded | Reported | Since trade |
|---|---|---|---|---|
| Alan ArmstrongSenate | Bought $1,001 - $15,000 | Mar 27, 2026 | Jul 21, 2026 | -4.3% |
Insiders at Universal Health Services
| Insider | Bought | Sold | Last filing | Past buys beat S&P | Score |
|---|---|---|---|---|---|
| Warren J. NimetzDirector | — | $852K | May 21, 2026 | — | — |
| Elliot J. Md Mba SussmanDirector | — | $346K | May 21, 2026 | — | — |
| Alan B. MillerChair | — | — | Nov 18, 2026 | — | — |
| Marc D. MillerCEO, President | — | — | Nov 12, 2026 | — | — |
| Maria Ruderman SingerDirector | — | — | May 21, 2026 | — | — |
| Eileen C. McDonnellDirector | — | — | May 21, 2026 | — | — |
| Nina Chen-LangenmayrDirector | — | — | May 21, 2026 | — | — |
| Steve FiltonCFO, President | — | — | Mar 30, 2026 | — | — |
| Matthew Jay PetersonPresident | — | — | Mar 30, 2026 | — | — |
| Edward H. SimPresident | — | — | Mar 30, 2026 | — | — |
Board links: companies that share insiders with UHS
Directors and executives who filed Form 4s for UHS and another company in the last 12 months.
- UHTUniversal Health Realty Income Trust Alan B. Miller Chair here · CEO, President at UHT · latest filing Nov 18, 2026
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
UHS stock: common questions
Are Universal Health Services insiders buying UHS stock?
No. No Universal Health Services insider reported an open-market purchase of UHS in the past 12 months.
Are Universal Health Services insiders selling UHS stock?
1 insider reported sales worth $128K over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is UHS's P/E ratio?
UHS trades at about 8.3 times trailing earnings, compared with a median of 25.0 for the Health Care sector.
What is UHS's 52-week range?
Over the past year UHS has traded between $141.00 and $243.12. It last closed at $175.66 on Nov 19, 2026.